Raised CD40L expression attenuates drug resistance in Adriamycin-resistant THP-1 cells

Acute myeloid leukemia is a common hematological malignancy that often exhibits strong drug resistance when treated using conventional chemotherapy. Although numerous studies have been carried out to develop methods of overcoming drug resistance, the results have generally been unsatisfactory. CD40...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Zhongxin, Chen, Qi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027340/
https://www.ncbi.nlm.nih.gov/pubmed/32104283
http://dx.doi.org/10.3892/etm.2020.8452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027340/
https://www.ncbi.nlm.nih.gov/pubmed/32104283
http://dx.doi.org/10.3892/etm.2020.8452

Ejemplares similares